Technology Transfer of a Cell-Based Influenza Vaccine

VaxThera is establishing local fill-and-finish manufacturing capacity in Colombia to help address vaccine supply gaps in Latin America and the Caribbean through regional technology transfer. The COVID-19 pandemic exposed severe supply chain vulnerabilities and inequitable vaccine access, underscoring the
need for sustainable regional manufacturing capacity. In line with PAHO’s call to advance beyond traditional egg-based vaccine production systems, this project supports the transfer of cell-based influenza vaccine manufacturing technology to VaxThera to enable localized production capacity. Activities include
workforce training, execution of three Process Performance Qualification batches, QC testing, and stability studies to support local manufacturing readiness. Data generated through the project will be submitted to Colombia’s INVIMA to enable commercial production. By strengthening regional production capabilities, the project aims to enhance pandemic preparedness and establish a foundation for future drug substance technology transfer and greater regional self-sufficiency.